Viewing Study NCT06224257


Ignite Creation Date: 2025-12-24 @ 6:35 PM
Ignite Modification Date: 2026-01-05 @ 6:18 PM
Study NCT ID: NCT06224257
Status: RECRUITING
Last Update Posted: 2025-08-05
First Post: 2024-01-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy and Safety of Linperlisib in Relapsed/Refractory Large Granular T Lymphocytic Leukemia
Sponsor: Institute of Hematology & Blood Diseases Hospital, China
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module